about
M19 modulates skeletal muscle differentiation and insulin secretion in pancreatic β-cells through modulation of respiratory chain activityGlutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreasMiniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase BProtein inhibitor of neuronal nitric oxide synthase (PIN) is a new regulator of glucose-induced insulin secretionDeregulation of hepatic insulin sensitivity induced by central lipid infusion in rats is mediated by nitric oxide.Excessive food intake, obesity and inflammation process in Zucker fa/fa rat pancreatic isletsQuercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway.Pharmacological interventions that directly stimulate or modulate insulin secretion from pancreatic beta-cell: implications for the treatment of type 2 diabetes.P2 purinergic signalling in the pancreatic beta-cell: control of insulin secretion and pharmacology.Obesity, insulin resistance and diabetes in the sand rat exposed to a hypercaloric diet; possible protective effect for IL1-β.Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.Effect of epiregulin on pancreatic beta cell growth and insulin secretion.Changes in the dimeric state of neuronal nitric oxide synthase affect the kinetics of secretagogue-induced insulin response.Cellular distribution and contribution of cyclooxygenase COX-2 to diabetogenesis in NOD mouse.Cellulose membrane supported peptide arrays for deciphering protein-protein interaction sites: the case of PIN, a protein with multiple natural partners.Counteracting neuronal nitric oxide synthase proteasomal degradation improves glucose transport in insulin-resistant skeletal muscle from Zucker fa/fa rats.Involvement of a central nervous pathway in yohimbine-induced insulin secretion.Insulinotropic agent ID-1101 (4-hydroxyisoleucine) activates insulin signaling in rat.Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.P2Y purinergic potentiation of glucose-induced insulin secretion and pancreatic beta-cell metabolism.Adrenergic inhibition of insulin secretion involves pertussis toxin-sensitive and -insensitive mechanisms.Effects of exposure to a 128-mT static magnetic field on glucose and lipid metabolism in serum and skeletal muscle of rats.Is static magnetic field exposure a new model of metabolic alteration? Comparison with Zucker rats.PIN-bodies: a new class of antibody-like proteins with CD4 specificity derived from the protein inhibitor of neuronal nitric oxide synthase.Effect of insulin on glucagon secretion mediated via glucose metabolism of pancreatic A cells in ducksDiabetes alters the responses of glucagon secreting cells and vascular bed to isoprenaline and forskolin in vitro in rat pancreasLong-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studiesEffect of n-hexacosanol on insulin secretion in the ratEvidence for two different imidazoline sites on pancreatic B cells and vascular bed in ratVanadyl sulphate differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo or in vitro exposure4-Hydroxyisoleucine: effects of synthetic and natural analogues on insulin secretionInsulinotropic effect of Citrullus colocynthis fruit extractsHuman pancreatic islets express the purinergic P2Y11 and P2Y12 receptorsIncreased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity
P50
Q24306087-1248BAC9-1380-46D1-B541-95482F45DC5BQ28298289-4A10B61C-158C-42E6-AE13-ADA74951076BQ28581242-95DBDCC7-41D5-4C3A-8437-A181802EFB03Q28583238-1A7E2107-7DB2-47AF-A32A-C9A127CEB49FQ33493414-98DCA56C-890F-4CDB-8F1C-87699B0DA2BAQ33986074-A49A5368-C9B8-4ED0-A22E-1781AF79864FQ34356099-40B7EDE5-E4C4-45D4-BC57-6FB30992865EQ36324890-F4A4A9E3-2F8D-4DD2-A5D7-4B3FEF82AF93Q37476197-3C7BD7D2-E000-4155-AB15-61D791AE4435Q39131874-DE24BF98-4419-426B-9CBB-0D003620462CQ40131658-43C9C1EA-68D3-4788-A44F-485D626E189AQ40341833-0E54695A-D300-48AC-8012-234BE6CBC97DQ40552125-4C21724C-3A68-459C-9AF9-EE75E08B6CA6Q40694582-3C8EC236-8F69-4438-A107-E856C5F13C32Q41166504-75ABEBFD-3282-4656-9CD0-B816EB0974F2Q42447822-ACAE350E-1FFA-4430-942A-991274018DE8Q44788516-78BA5D17-67D8-477A-968D-87996E19CA15Q44843307-5D04AF4F-646E-41AA-85B6-9CB3AC52E345Q44900784-4266E5D0-905D-4694-8415-9F87A0F1DB44Q45161270-EF7B93B0-0065-440B-8537-AE962AEF243BQ45224994-6B06E5DA-45DE-4E1C-AAA0-E3B23A75469EQ45583168-1792E8B2-60DE-4982-8856-3DDD35180403Q46189909-6673FD17-6285-43F3-B8C1-697812342572Q54636589-3E369A41-288F-4642-93D8-97633679D2D0Q67276631-3A361CB1-032C-47E4-930C-28FCEEE81D43Q68239418-79872A21-B69B-4C31-83AE-B1492C8C51B4Q71796201-ED510CF5-768A-4B03-867B-B05E24D50CEFQ72281616-D1619136-D21E-44AF-B918-FB5871EDD332Q72296938-1318B725-6DCA-466F-9E76-E1901DACB383Q73010677-D5125373-332C-42EB-9007-1E9DD7709B0EQ73525972-E455742B-B94D-4556-B4E6-E460466D6F71Q74049086-0BAC2B01-0ABC-4F3D-A2F5-6F1074789100Q81826886-B7794C0B-018F-4293-8698-A282D75CEFBFQ84778382-4224D890-4F8E-4FCE-9B8F-A4A5D9FBE41B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rene Gross
@ast
Rene Gross
@en
Rene Gross
@es
Rene Gross
@nl
Rene Gross
@sl
type
label
Rene Gross
@ast
Rene Gross
@en
Rene Gross
@es
Rene Gross
@nl
Rene Gross
@sl
prefLabel
Rene Gross
@ast
Rene Gross
@en
Rene Gross
@es
Rene Gross
@nl
Rene Gross
@sl
P106
P1153
7403106641
P21
P31
P496
0000-0001-5884-3607